Structural Insights into APOBEC3-Mediated Lentiviral Restriction

Mammals have developed clever adaptive and innate immune defense mechanisms to protect against invading bacterial and viral pathogens. Human innate immunity is continuously evolving to expand the repertoire of restriction factors and one such family of intrinsic restriction factors is the APOBEC3 (A...

Full description

Bibliographic Details
Main Authors: Krista A. Delviks-Frankenberry, Belete A. Desimmie, Vinay K. Pathak
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/12/6/587
_version_ 1797566885473026048
author Krista A. Delviks-Frankenberry
Belete A. Desimmie
Vinay K. Pathak
author_facet Krista A. Delviks-Frankenberry
Belete A. Desimmie
Vinay K. Pathak
author_sort Krista A. Delviks-Frankenberry
collection DOAJ
description Mammals have developed clever adaptive and innate immune defense mechanisms to protect against invading bacterial and viral pathogens. Human innate immunity is continuously evolving to expand the repertoire of restriction factors and one such family of intrinsic restriction factors is the APOBEC3 (A3) family of cytidine deaminases. The coordinated expression of seven members of the A3 family of cytidine deaminases provides intrinsic immunity against numerous foreign infectious agents and protects the host from exogenous retroviruses and endogenous retroelements. Four members of the A3 proteins—A3G, A3F, A3H, and A3D—restrict HIV-1 in the absence of virion infectivity factor (Vif); their incorporation into progeny virions is a prerequisite for cytidine deaminase-dependent and -independent activities that inhibit viral replication in the host target cell. HIV-1 encodes Vif, an accessory protein that antagonizes A3 proteins by targeting them for polyubiquitination and subsequent proteasomal degradation in the virus producing cells. In this review, we summarize our current understanding of the role of human A3 proteins as barriers against HIV-1 infection, how Vif overcomes their antiviral activity, and highlight recent structural and functional insights into A3-mediated restriction of lentiviruses.
first_indexed 2024-03-10T19:33:45Z
format Article
id doaj.art-710a8f87787a467888f845029a01ee67
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T19:33:45Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-710a8f87787a467888f845029a01ee672023-11-20T01:55:55ZengMDPI AGViruses1999-49152020-05-0112658710.3390/v12060587Structural Insights into APOBEC3-Mediated Lentiviral RestrictionKrista A. Delviks-Frankenberry0Belete A. Desimmie1Vinay K. Pathak2Viral Mutation Section, HIV Dynamics and Replication Program, National Cancer Institute at Frederick, Frederick, MD 21702, USAViral Mutation Section, HIV Dynamics and Replication Program, National Cancer Institute at Frederick, Frederick, MD 21702, USAViral Mutation Section, HIV Dynamics and Replication Program, National Cancer Institute at Frederick, Frederick, MD 21702, USAMammals have developed clever adaptive and innate immune defense mechanisms to protect against invading bacterial and viral pathogens. Human innate immunity is continuously evolving to expand the repertoire of restriction factors and one such family of intrinsic restriction factors is the APOBEC3 (A3) family of cytidine deaminases. The coordinated expression of seven members of the A3 family of cytidine deaminases provides intrinsic immunity against numerous foreign infectious agents and protects the host from exogenous retroviruses and endogenous retroelements. Four members of the A3 proteins—A3G, A3F, A3H, and A3D—restrict HIV-1 in the absence of virion infectivity factor (Vif); their incorporation into progeny virions is a prerequisite for cytidine deaminase-dependent and -independent activities that inhibit viral replication in the host target cell. HIV-1 encodes Vif, an accessory protein that antagonizes A3 proteins by targeting them for polyubiquitination and subsequent proteasomal degradation in the virus producing cells. In this review, we summarize our current understanding of the role of human A3 proteins as barriers against HIV-1 infection, how Vif overcomes their antiviral activity, and highlight recent structural and functional insights into A3-mediated restriction of lentiviruses.https://www.mdpi.com/1999-4915/12/6/587APOBEC3Gcytidine deaminationrestriction factorVifsubstrate selectionhypermutation
spellingShingle Krista A. Delviks-Frankenberry
Belete A. Desimmie
Vinay K. Pathak
Structural Insights into APOBEC3-Mediated Lentiviral Restriction
Viruses
APOBEC3G
cytidine deamination
restriction factor
Vif
substrate selection
hypermutation
title Structural Insights into APOBEC3-Mediated Lentiviral Restriction
title_full Structural Insights into APOBEC3-Mediated Lentiviral Restriction
title_fullStr Structural Insights into APOBEC3-Mediated Lentiviral Restriction
title_full_unstemmed Structural Insights into APOBEC3-Mediated Lentiviral Restriction
title_short Structural Insights into APOBEC3-Mediated Lentiviral Restriction
title_sort structural insights into apobec3 mediated lentiviral restriction
topic APOBEC3G
cytidine deamination
restriction factor
Vif
substrate selection
hypermutation
url https://www.mdpi.com/1999-4915/12/6/587
work_keys_str_mv AT kristaadelviksfrankenberry structuralinsightsintoapobec3mediatedlentiviralrestriction
AT beleteadesimmie structuralinsightsintoapobec3mediatedlentiviralrestriction
AT vinaykpathak structuralinsightsintoapobec3mediatedlentiviralrestriction